Status:
COMPLETED
Prenatal Iron Status and Its Association With Cord Blood and Infant Ferritin Level
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Iron-deficiency
Eligibility:
All Genders
Brief Summary
Iron deficiency (ID) in early life is associated with significant morbidities. Most fetal iron required for infant growth is acquired in the third trimester from maternal iron store. However, how pren...
Detailed Description
Iron deficiency (ID) is the most common micronutrient deficiency globally. Pregnant women and young children are at risk of ID. During pregnancy, there is an increased demand for iron to accommodate t...
Eligibility Criteria
Inclusion
- Women who carried a singleton pregnancy without any history of thyroid dysfunction, hyperemesis gravidarum, autoimmune disease, or any other major medical condition with cord blood available were eligible for this study
Exclusion
- multiple pregnancy, preterm delivery at less than 37 weeks of gestation, infants with congenital anomalies, syndromal diseases, chronic renal or hepatic diseases, metabolic disease, chronic gastrointestinal diseases and/or malabsorption
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT04699045
Start Date
January 1 2014
End Date
July 1 2016
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong